Statins and ARBs on Rheumatoid Activity
ConditionRheumatoid Arthritis
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-65
SponsorSherief Abd-Elsalam
About this trial
Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients
Eligibility criteria
Qualifiers
Rheumatoid arthritis.
Disqualifiers
Pregnant or lactating
Hepatic or renal impairment.
Trial design
Treatments tested in this trial
- Angiotensin receptor blockers
- Statins
Treatment groups
45 Participants
are divided into 3 treatment groupsSponsors and collaborators
Sherief Abd-Elsalam
Lead sponsor
Tanta University
Sponsor institution
Source ClinicalTrials.gov